Wound Cleanser Products Market to Touch US$ 1.5 Billion by the end of 2025

Persistence Market Research has analyzed various facets of the wound cleanser products market from a global standpoint and has skilfully presented these in its new research publication titled “Wound Cleanser Products Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”. This report covers various trends, opportunities, drivers and restraints influencing the growth of the global wound cleanser products market along with regional analysis, competitive scenario and revenue forecasts. This analysis focuses on each segment and sub-segment of the global market based on which the analysts have given their insights regarding various market dynamics.

Global Wound Cleanser Products Market: Forecast Insights

The global wound cleanser products market is expected to grow at a sluggish CAGR of 3.2% during the forecast period. The global wound cleanser products market is anticipated to reach a valuation of about US$ 1.9 Bn by the end of the assessment year in 2025, up from an estimated US$ 1.5 Bn in 2017.

Browse Full Research Report: https://www.persistencemarketresearch.com/market-research/wound-cleanser-products-market.asp

Global Wound Cleanser Products Market: Segmental Insights

The global wound cleanser products market is segmented by product type, by form type, by end user, by wound type and by region.

By form type, gels segment is expected to outpace other segments and reflect a CAGR of 4.3% during the forecast period. Solutions segment in this category is the largest in terms of value.

By wound type, chronic wounds segment reflects high potential for growth and is projected to expand at a CAGR of 5.2% during the period of assessment.

By end user, hospitals is the largest and most lucrative end user segment and is anticipated to reflect a valuation of around US$ 700 Mn by the end of the assessment year, thus leading the global market.

By product type, wetting agents segment is expected to hold a high market share and reach a valuation of more than US$ 740 Mn by the end of the year of assessment.

By region, Asia Pacific is poised to be the second largest, reflecting very high potential with respect to growth. The wound cleanser products market in this region is poised to register a CAGR of 4.5%.

Request and Download Sample Report https://www.persistencemarketresearch.com/samples/11689

Rising prevalence of chronic wounds, favorable reimbursement ratio, expansion of product line, rising adoption of advanced wound care products, increasing demand for advanced wound care products in home care settings, rising prevalence of diabetes, increasing focus of healthcare facilities on educational programs, a growing awareness among patients, high availability of wound and burn care products in the market, growing acceptance of standardized protocols to manage complex wounds, expansion in emerging economies, collaborative agreements among manufacturers and distributors, high focus on acquisitions to strengthen the product portfolio and increasing preference for accelerated wound healing are pushing the growth of the global wound cleanser products market. However, aspects such as high demand for low frequency dressing change in acute care settings, lack of skilled labor, and high cost of advanced wound care dressings is hindering the growth of the global wound cleanser products market.

Global Wound Cleanser Products Market: Competitive Scenario

The research report on the global wound cleanser products market features a detailed research analysis on competition that includes various key players in the market. Details such as SWOT analysis, company overview, developments, product portfolio, strategies and financials of major companies such as Smith & Nephew Plc., Reckitt Benckiser Group Plc., B. Braun Melsungen AG, Convatec Group Plc., Johnson & Johnson Services Inc., C. R. Bard, Inc., Coloplast Group, 3M, Molnlycke Healthcare, Medtronic Plc., and Derma Sciences Inc., are covered in this research report.

Buy Full Herpes Marker Testing Market Report @ https://www.persistencemarketresearch.com/checkout/11689

Advertisements

Laptop Cooling Pads Market To Garner US$ 430 Million By The End Of 2025

Numerous facts about laptop cooling pads have been revealed in the market study titled “Laptop Cooling Pad Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”. This research report has been published by Persistence Market Research and it provides information on the factors influencing the growth of the global market for laptop cooling pads. This influence is studied across various regions as its magnitude changes from geography to geography, thus impacting the overall market growth. Key trends, developments, growth fueling aspects as well as challenges have been enumerated in this research report. A detailed market segmentation has been carried out to cover a 3600 view of the global market thus capturing the pulse of the market. The study also includes opportunities that can be tapped to improve the current market position and also assess future options to maximize profits. With the current market estimations, past market statistics and ongoing trends, a glimpse of the future has been slated for a period of eight years that can be used to evaluate future market demands and plan moves accordingly.

Global Laptop Cooling Pad Market: Forecast Highlights

The research report covers future market projections of the global market for laptop cooling pads. The current scenario reveals a valuation of around US$ 270 Mn (in 2017). This scenario is expected to rise to reach a higher value of more than US$ 430 Mn by the end of the year of forecast (2025). The global laptop cooling pad market is projected to grow at a high CAGR of 5.9% throughout the period of forecast, 2017-2025.

Global Laptop Cooling Pad Market: Growth Influencing Aspects

Adoption of preventive measures to avoid laptop premature failure, increasing import and export of electronic goods, continuous use of laptops in several industry verticals, increased adoption of laptops for gaming purposes coupled with a boom in the gaming industry, increased adoption of laptop accessories, government initiatives to promote the manufacturing sector and rising disposable income and decreasing average selling price have spurred the growth of the global laptop cooling pad market.

Request to Browse Full Table of Content, figure and Tableshttps://www.persistencemarketresearch.com/market-research/laptop-cooling-pad-market/toc

However, increased market penetration of smartphones and tablets, high import tariffs and taxes on consumer electronic goods, high cost of laptop cooling pads, nonstandard products degrading product quality and limited awareness about advanced technologies are the challenges that are limiting the growth of the global laptop cooling pad market.

Global Laptop Cooling Pad Market: Segmental Snapshot

The global laptop cooling pad market is segmented on the basis of product type, sales channel, end user and region.

With respect to region, North America reflects high lucrativeness for the growth of the global market for laptop cooling pads. The laptop cooling pad market in this region is anticipated to grow at a high CAGR of 6.8% to reach a valuation of more than US$ 150 Mn by the end of the year of assessment.

Report overviewhttps://www.persistencemarketresearch.com/market-research/laptop-cooling-pad-market.asp

By sales channel, the e-commerce/online segment is expected to dominate the global market with a high market valuation and growth rate. During the forecast period, this segment is anticipated to rise at a robust CAGR of 6.6% and also reflect a high Y-o-Y growth.

On the basis of product type, active cooling pads are highly adopted and this segment is likely to lead the market in the coming years.

Request to sample reporthttps://www.persistencemarketresearch.com/samples/18907

By end user, the residential sector shows high inclination towards using cooling pads for laptops. The residential segment is poised to reflect a revenue generation of about US$ 336 Mn by the end of 2025 and is projected to grow at 6.7% CAGR throughout the forecast period.

The research report includes assessment on key companies operating in the laptop cooling pads market. Companies such as Targus, Honeywell, Cooler Master Co., Ltd., Thermaltake Technology Co., Ltd., GIGA-BYTE Technology Co., Ltd., Zalman Tech Co., Logitech, Zebronics, Portronics, HAVIT, Antec Inc., Belkin International, Inc., and NZXT have been profiled in this research report.

Get full report nowhttps://www.persistencemarketresearch.com/checkout/18907

ePRO, E-Patient Diaries and eCOA Market Slated to Value at US$ 2,986 Million by the end of 2025

Technological advancements in the healthcare sector have resulted in the adoption of new technologies for clinical trials. Some of these technologies include Electronic Clinical Outcome Assessments (eCOA) and Electronic Patient Diaries (E-Patient Diaries). eCOA uses advanced mobile technology such as smartphones, tablets, and personal computers to allow patients, clinicians, and their caregivers to directly report outcomes. eCOA generates highly accurate data that allows for a better understanding of the patient experience in clinical trials. Electronic patient diaries is an electronic diary or tool that is used in clinical trials or in disease treatment to either evaluate the patient’s condition or to measure treatment compliance. A new research report by Persistence Market Research provides an overview of the ePRO, e-patient diaries and eCOA market. The report is titled ‘ePRO, E-Patient Diaries and eCOA Market:Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025’. According to the research forecast in the report, the global market is expected hold a value of just under US$ 958 Mn in 2017, and is expected to reach a value of about US$ 2,986 Mn in 2025, growing at an exponential CAGR of 15.3%.

Global ePRO, E-Patient Diaries and eCOA Market: Dynamics

There are a lot of factors that have helped boost revenue growth of the global ePRO, e-patient diaries and eCOA market. One of the main factors is the boom in technological advancements in the healthcare sector and adoption of mobile technologies. The use of electronic devices to collect clinical report outcomes has helped the market grow at a higher pace.

Request to Browse Full Table of Content, figure and Tableshttps://www.persistencemarketresearch.com/market-research/epro-epatient-diaries-and-ecoa-market/toc

However there are some restraints that are limiting the growth of the global market. As these technologies require internet connectivity to work perfectly, there are severe limitations in the scope of use. Also, in many places people are not much aware about these advanced technologies and clinics are faced with the issue of finding skilled professionals with the required technical know-how.

Report overviewhttps://www.persistencemarketresearch.com/market-research/epro-epatient-diaries-and-ecoa-market.asp

Global ePRO, E-Patient Diaries and eCOA Market: Segmental Highlights

This research report has systematically bifurcated the market into different segments thereby simplifying the analysis of the global ePRO, e-patient diaries and eCOA market. The segmentation is done on the basis of type of solution, end user, modality type, and region.

The regional markets analyzed in the report include North America, Latin America, Europe, APAC and MEA. Among these, North America is expected to dominate the global market in terms of value during the forecast period. However, Asia Pacific is projected to witness the highest CAGR of 16.6% during the study period.

Request to sample reporthttps://www.persistencemarketresearch.com/samples/11506

In terms of solution type, the market is dominated by the eCOA segment with a market valuation of just under US$ 636 Mn in 2017. The e-patient diaries segment is expected to hold a market value of about US$ 323 Mn in 2017.

On the basis of modality type, the market is dominated by the mobile devices segment, which is expected to reach a market value of around US$ 1,578 Mn by the end of 2025.

Clinical trial sponsors segment dominates the segments on the basis of end user. This segment is expected to grow at a CAGR of 16.2% during the forecast period.

There are a lot of new entrants in the business as well as some top companies already ruling the global market for ePRO, e-patient diaries and eCOA. Some of the key players mentioned in the report are Bracket Global LLC, Parexel International Corporation, Kayentis, SAS, Medidata Solutions, Inc., ArisGlobal LLC, CRF Health, ERT Clinical, and ICON plc.

Get full report nowhttps://www.persistencemarketresearch.com/checkout/11506

LED Lighting Controllers Market To Garner US$ 5 Billion By The End Of 2025

To understand the various aspects of the global LED lighting controllers market, Persistence Market Research recently conducted a research study on LED controllers across the globe and has presented all insights in a research publication titled “LED Lighting Controllers Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”.Several facets of the global market are analyzed across the key regions of North America, Latin America, Europe, Asia Pacific (APAC) and Middle East and Africa (MEA). This reflects an all-inclusive angle of the research with which a realistic picture of the entire market can be drawn. Weighted market segmentation along with extensive analysis on various segments of the global LED lighting controllers market is presented in a systematic and orderly format.

The research report on the global LED lighting controllers market states that the global market is projected to soar at a stellar CAGR of 17.4% during the forecast period to reach a valuation of above US$ 5 Bn by 2025 end from a value of around US$ 1,400 Mn in 2017.

The global LED lighting controllers market is segmented on the basis of connectivity, by end user, by technology and by region.

Request to Browse Full Table of Content, figure and Tableshttps://www.persistencemarketresearch.com/market-research/led-lighting-controllers-market/toc

By connectivity, wireless LED lighting controller segment is expected to be the fastest growing segment and is expected to reflect a CAGR of 21.1% during 2017-2025 and reach an estimation above US$ 2,600 Mn by the end of the assessment year. This segment is likely to lead the global market.

By region, Asia Pacific is the largest with a higher valuation and high growth rate in the global LED lighting controllers market. The LED lighting controller market in this region is estimated to reach US$ 2,067.5 Mn by 2025 end and is projected to rise at a 19.4% CAGR during the forecast period.

Report overviewhttps://www.persistencemarketresearch.com/market-research/led-lighting-controllers-market.asp

By end user, street lighting segment is likely to dominate the global market with respect to high market valuation by the end of the assessment year. The residential segment is poised to grow at the highest CAGR of 21.0% during the period of forecast.

By technology, time scheduling segment is the largest and most lucrative as it is estimated to touch a higher valuation by 2025 end and is expected to grow at a high CAGR of 20.6% throughout the period of forecast.

Request to sample reporthttps://www.persistencemarketresearch.com/samples/20116

Several drivers fuelling the growth of the global LED lighting controllers market include rapid development of smart lighting infrastructure, increased adoption of smart lighting solutions in real estate, increasing partnerships with government authorities, various benefits of LED lighting controllers, growing demand for better lighting infrastructure, increasing lighting projects worldwide, increasing green building projects, rising demand for LED lighting controllers in the night club industry, growing applications of lighting solutions in the healthcare industry, increased government spending on smart city projects, rising inclination towards adoption of smart technology products, growing smart street lighting projects, favorable government initiatives and rising adoption of LED lighting controllers in retail stores. Challenges faced by wireless lighting control systems such as high maintenance and periodic battery change, less awareness about modern and smart lighting fixtures, challenges associated with centralized lighting control systems and high installation costs are hindering the growth of the global market for LED lighting controllers.

The report includes details on key companies operating in the global market. Profiles of companies such as Hubbell Lighting, Inc., GE Lighting, LLC, OSRAM Licht AG, Royal Philips NV, Acuity Brands Lighting, Inc., Eaton Corporation, Schneider Electric S.E, Honeywell International, Lutron Electronics and CREE, Inc., are included in this research study.

Get full report nowhttps://www.persistencemarketresearch.com/checkout/20116

Operating Tables Market Slated to Value at US$ 1,150 Million by the end of 2025

There have been several innovations in operation theater equipment globally and hospitals across the world can be seen demanding advanced operating tables to enhance the efficacy of the surgical process. Through a new report titled ‘Operating Tables Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025,’ Persistence Market Research aims to track the performance of the global operating tables market and presents key insights on the factors impacting revenue growth of the global market over an eight year forecast period from 2017 to 2025. According to the report estimations, the global operating tables market is estimated to reach a market valuation of just under US$ 850 Mn by 2017 end, and this is projected to increase to a little more than US$ 1,150 Mn by the end of the forecast period in 2025, registering a CAGR of 3.9% in terms of value.

Request to Browse Full Table of Content, figure and Tableshttps://www.persistencemarketresearch.com/market-research/operating-tables-market/toc

The global operating tables market is segmented on the basis of Product Type into General Surgical Tables, Radiolucent Operating Tables, Specialty Surgery Tables (Orthopedic Surgery Tables, Laparoscopic Operating Tables, Neurosurgical Operation Tables, Bariatric Surgery Tables), and Pediatric Operating Tables. General Surgical Tables is the largest segment, estimated to represent US$ 499.7 Mn, or 58.8% share of the global market in 2017 and is projected to reach US$ 654.5 Mn, or 56.6% share of the global market by 2025 end, expanding at a CAGR of 3.4% over the forecast period. This is the dominant product type as well as the most attractive market, registering an attractiveness index of 2.1 during the forecast period.

Report overviewhttps://www.persistencemarketresearch.com/market-research/operating-tables-market.asp

The global operating tables market is segmented on the basis of Technology into Powered Operating Tables, Non-powered/Manual Operating Tables, and Hybrid Operating Tables. Non-powered/Manual Operating Tables is the largest segment, estimated to represent US$ 423.4 Mn, or 49.8% share of the global market in 2017, growing at a CAGR of 3.7% over the forecast period.

The global operating tables market is segmented on the basis of End User into Hospitals, Clinics, and Ambulatory Surgical Centers. Hospitals is the largest segment with a market valuation projected to reach US$ 729.0 Mn by the end of 2025. However, Clinics is the fastest growing segment, registering the highest segmental CAGR of 4.7% in terms of value during the period of assessment.

Request to sample reporthttps://www.persistencemarketresearch.com/samples/3789

Persistence Market Research tracks the performance of the global operating tables market across the key geographies of North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. There is close competition among North America and Asia Pacific in terms of market value, with North America projected to reach a market valuation of US$ 363.6 Mn and Asia Pacific anticipated to be valued at US$ 370.0 Mn by the end of 2025. However, Asia Pacific is the fastest regional market, witnessing a growth rate of 4.8% during the period of study. Asia Pacific is projected to be the most attractive regional market with an attractiveness index of 1.9 during the forecast period.

The report features some of the top companies in the global operating tables market including the likes of STERIS plc, Skytron LLC, Siemens Medical Solutions USA, Inc., Stryker Corporation, Alvo Medical, Mizuho OSI, Getinge-Maquet, Germany Holding GmbH, Schaerer Medical USA, Inc., OPT Surgisystems S.R.L, NUVO, Inc., Hill-Rom Holdings Inc., Medifa GmbH & Co. KG, Allengers Medical Systems Limited, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., BRUMABA GmbH & Co KG, AGA Sanitaetsartikel GmbH, Lojer Group, Famed ?ywiec Sp. z o. o., Merivaara Corp., AMTAI Medical Equipment, Inc.

Get full report nowhttps://www.persistencemarketresearch.com/checkout/3789

Antibacterial Drugs Market Going to Rake US$51,447.6 Mn by the end of 2025

As competition grows strong in the global antibacterial drugs, the leading players are finding it more convenience to collaborate with rivals to expand their product offering as well regional footprint worldwide. In a new study, Transparency Market Research (TMR) has identified Bayer AG, Pfizer Inc., Sanofi, GlaxoSmithKline Plc. (GSK), Merck & Co., Inc., AstraZeneca, Johnson and Johnson, Bristol Myers Squibb Company, Novartis Ag, and Allergen Plc as some of the most prominent enterprises operating in the global antibacterial drugs market. To gain a competitive edge, Pfizer signed an agreement with AstraZeneca in August 2016. This collaboration was intended to acquire the commercialization and development rights of late-stage small molecule anti-infective business. Besides this, the market witnessed several other partnerships, collaborations, and acquisitions aimed at catapulting businesses to the forefront of the global antibacterial drugs market.

Despite strategies toyed by businesses to gain traction, the subpar pace of growth is unlikely to change for the global antibacterial drugs market. According to TMR, the global market is likely to exhibit a CAGR of 1.5% between 2017 and 2025. Given the growth pace, the market is expected to reach US$51,447.6 mn by the end of 2025, from US$45,325.0 mn in 2016. While North America held dominance in the global antibacterial drugs market in 2016, TMR forecasts sluggish growth for the region through the forecast period. In terms of drug-class, the B-lactam segment led the market in 2016.

Browse Full Research Report: https://www.transparencymarketresearch.com/antibacterial-drugs-market.html

Antibacterial Drugs Market Witnesses Threat from Looming Patent Expiries

The rising population of aged people, escalating number of bacterial strains, which are multidrug resistant, and the rising demand for effective yet affordable antibacterial drugs will give the market considerable boost over the forecast period. In addition, TMR predicts the global antibacterial drugs market to gain significantly from the increasing incidence of infectious diseases. It is also likely to gain from the rising demand for innovative molecules. Despite the aforementioned growth prospects, the advent of genetic drugs for antibacterial activities threatens the overall market. The looming patent expiries are also identified as key factors restraining the market. Furthermore, the research and development activities conducted in the field is insufficient as per many experts. This could pose significant threat to the overall antibacterial drugs market in the coming years.

Opportunities Prevalent in Emerging Nations to Boost Growth in Near Future

In the coming years, the market is likely to gain from factors such as the improved efficacy, fewer side effects, and reduced time of action. In addition, opportunities prevalent across emerging nations will enable the global antibacterial drugs market stay afloat during the forecast period. According to TMR, the market will gain considerable traction in emerging nations such as India and China.

In the last few years, several synthesis inhibitors have gone off-patent, which has made TMR predict that several of the drugs under clinical trial could be approved in the coming years. The likelihood of benefiting from the commercialization of drug-resistant infections treatment is also rising. Despite the influx of novel protein synthesis inhibitors, vaccines will remain the class of drugs contributing the most revenue toward the global antibacterial drugs market. These factors will enable growth in the global antibacterial drugs market in the coming years.

Diabetes Devices Market Going to Rake US$66,053.1 Mn by the end of 2025

Transparency Market Research observes that the competitive landscape in the diabetes devices market is moderately consolidated. Some of the leading companies in this market are Medtronic plc, Eli Lilly and Company, Sanofi S.A., F. Hoffmann-La Roche Ltd, and Novo Nordisk A/S. Most of these companies are focusing on expanding their business in developing parts of the world to tap into the wide consumer base. Furthermore, developing and commercializing diabetes devices that are simple yet affordable will be a winning strategy of these players in the near future.

According to the research report, the global diabetes devices market is expected to be worth US$66,053.1 mn by the end of 2025 from US$37,220.8 mn in 2016. During the forecast period of 2017 and 2025, the global market is expected to rise at a CAGR of 6.7%. Out of the wide range of products to manage diabetes, the global market is likely to be driven by glucose monitoring devices and the products available under this segment. As of 2016, the blood glucose meters held a share of 59.1% in terms of revenue in the global market. Geographically, the global market is dominated by North America due to higher awareness about the disease.

Browse Full Research Report: https://www.transparencymarketresearch.com/diabetes-devices-market.html

The global diabetes devices market is primarily being driven by the soaring diagnostic rate of diabetes across the globe. The high occurrence of this disease is attributable to the highly sedentary lifestyles, excessive stressful living, poor dietary choices, and high alcohol consumption. The improving rate of diagnoses has also led to increased uptake of diabetes devices in recent years. Furthermore, affordable price of devices such as self-monitoring blood glucose meters, lancets, testing strips, and continuous monitoring devices are have also had a positive influence on the overall market. The analysts state the growing awareness about way to manage the disease better is also projected to spike the demand in the global market.

Rise in the number of diabetics due to occurrence of conditions such as jaundice, dengue, pregnancy, and old age has also created a spur in the demand of diabetes devices. Thus, a large pool of patients is projected to fuel market growth in the near future. Growing investments in developing better home diagnostic machines and efficient solutions are expected to generate greater revenues. Convenience of using these devices enabled by their simple design has also been identified as a key market growth for the global market. Thus, the ability to make a safer and effective diagnosis of diabetes is expected to benefit the vendors in the global market.

On the downside, the global market is being affected by the lack of awareness about diabetes and its management in the rural parts of the world. The poor rate of knowledge and low rate of inclination to treat the disease has created a major negative impact on the overall market. Furthermore, diabetes devices continue to be unaffordable to several patients in the low-income category. Thus, the relative high cost of these devices and treatment coupled with lack of reimbursement issues is likely to hamper the market growth.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research

State Tower,

90 State Street, Suite 700,

Albany NY – 12207

United States

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Glycated Hemoglobin Testing Market Will Rake US$ 705 Mn by the end of 2026

Increasing incidences of diabetes have propelled the need for improved diagnostics in the global healthcare devices. Companies manufacturing critical diagnostic devices are focusing on facilitating products for effective tests. The use of glycated hemoglobin in diagnosis of diabetes mellitus continues to gain traction, creating a steady demand for glycated hemoglobin testing. Transparency Market Research’s recent report on the global glycated hemoglobin testing market delivers a forecast outlook on growing demand for these tests in diagnosis of prevalent disorders such as diabetes.

According to the report, the global market for glycated hemoglobin testing is expected to be worth US$ 705 Mn by the end of 2026. During the forecast period, 2017-2026, the global glycated hemoglobin testing market is expected to expand at a CAGR of 8.8%. Leading manufacturers of medical devices are anticipated to be key participants in the global expansion of the glycated hemoglobin testing market. Companies namely, Siemens Healthcare, Bio-Rad Laboratories, Arkray, Ceragem Medisys, Bayer, Chek Diagnostics, DiaSys Diagnostic Systems, Daiichi Biotech, Diazyme Laboratories, Erba Mannheim, EKF Diagnostics, Human Diagnostics, Menarini, Lite-On Technology, Mindray Medical, TaiDoc Technology, Sebia, Randox Laboratories, Trinity Biotech, and Tosoh Bioscience are expected to be observed as leading manufacturers of devices used in glycated hemoglobin tests.

Browse Full Research Report: https://www.transparencymarketresearch.com/glycated-hemoglobin-testing-market.html

Key findings from the report reveal that the global market for glycated hemoglobin testing will witness a significant traction in demand for laboratory based tests. While patients are actively opting for point-of-care glycated hemoglobin testing, laboratories continue to be the key medium where these tests can be executed effectively. In 2017, more than US$ 240 Mn worth of revenues are anticipated to be procured in the global glycated hemoglobin testing market from laboratory based tests. The study also projects that by the end of 2026, point-of-care glycated hemoglobin tests will account for over one-fourth revenue share of the global market.

A regional analysis on the global glycated hemoglobin testing market has been provided in the report. Increasing presence of diabetics in the US and Canada has been observed as the governing factors for fuelling the growth of the glycated hemoglobin testing market in North America. In the overall glycated hemoglobin testing market, North America is expected to dominate in terms of global revenue share. In 2017, the glycated hemoglobin testing market in North America is estimated to be worth over US$ 110 Mn. Meanwhile, the demand for these tests is also expected to gain traction in Europe and the Asia-Pacific excluding Japan (APEJ) region. Improving healthcare infrastructure and diabetic dietary lifestyles of consumers in these regions are observed as the superficial factors driving the growth of glycated hemoglobin testing market in Europe and the APEJ region.

On the basis of techniques, glycated hemoglobin tests can be carried out through immunoassays and chromatography, among others. In 2017, the sales of devices in the global glycated hemoglobin testing market for chromatography and immunoassay techniques are estimated to showcase near-equal revenue share. Moreover, the use of these techniques will depend largely upon the end-use of glycated hemoglobin tests. Hospitals are anticipated to emerge as the largest end-users in the global glycated hemoglobin testing market. In terms of revenues, the end-use of glycated hemoglobin testing in hospitals is expected to rake in US$ 275 Mn globally by the end of 2026. Diagnostic centers are also estimated to emerge as leading end-users of glycated hemoglobin testing in the global market.

Transcriptomics Technologies Market Will Rake US$4.6 Bn by the end of 2019

Transparency Market Research, a global market intelligence consultancy, has published a market study on the global transcriptomics technologies market for the 2013-2019 period. According to this report, the global transcriptomics technologies market will rise at a CAGR of 15.90% from 2013 to 2019 to reach a valuation of US$4.6 bn by the end of the forecast period. The market’s valuation in 2012 was US$1.65 bn. The report is titled “Transcriptomics Technologies Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”.

The report says that the global transcriptomics technologies market will witness substantial growth in the coming years due to several reasons. Transcriptomics research involves studying the structure and function of RNA present in a cell.Presently, transcriptome analysis of several organisms is assisted using next-generation sequencing platforms in the preliminary phase followed by polymerase chain reactions, gene regulation technologies, and microarrays in the latter part. The coalition of these technologies is used for drug discovery, clinical diagnosis of diseases, medical research, and others. With the ever-increasing demand for targeted therapeutics and continual improvement of healthcare infrastructure, the commercial usage of transcriptomics technologies holds promise. Transcriptomics research allows the development of newer therapeutics and diagnostics and further advancement of the existing line of treatment for medical conditions.

Browse Full Research Report: https://www.transparencymarketresearch.com/transcriptomics-technologies-market.html

The report says that in the transcriptomics technologies market, the key application segments undergo consistent development in order to offer added value to users. For instance, the utilization of transcriptomics technologies has benefitted the pharmaceutical and biotechnology fields; other fields are also deriving the advantages of this technology for mutual benefits of both the technology and the application field. Laboratories attempting to use biomarkers and newer gene sequencing methods is an example of this.

The need for the development of adequate equipment in healthcare organizations and laboratories, the growing awareness about transcriptomics technologies globally, and increased participation of government bodies in transcriptomics research are some other factors driving this global market.

However, growth of the transcriptomics technologies market is hampered due to certain factors cited in this report. These include the unavailability of advanced equipment needed for biological computation, unavailability of services essential to analyzing complex information, and an overall deficit of technicians that have expertise in the subject.

The report divides the global transcriptomics technologies market into the regional segments of North America, Asia Pacific, Europe, and Rest of the World. Among the regional segments, Asia Pacific will exhibit a substantial uptake of these technologies and the fastest growth rate in the transcriptomics technologies market during the forecast period. Ongoing infrastructural development for improved healthcare and increased acceptance of novel biotechnology research are the reasons for this.

In 2012, North America led the global transcriptomics technologies market, contributing more than 35% of the revenue in the global market. The presence of advanced healthcare infrastructure, which includes well-equipped research facilities, increased awareness of biotechnology research, and the high number of initiatives taken by governments to promote research activities are the reasons for the dominant position of North America in this market.

The report mentions the top players that operate in the global transcriptomics market. These are Life Technologies Corporation, F-Hoffmann La Roche Ltd., Thermo Fisher Scientific, Illumina Inc., Agilent Technologies, and Affymetrix Inc.

Companion Diagnostics Market Will Rake US$5.6 Bn by the end of 2019

A new Transparency Market Research report states that the global companion diagnostics market stood at US$1.8 bn in 2013 and is predicted to reach US$5.6 bn by 2019. It is predicted to expand at a whopping CAGR of 18.0% between 2013 and 2019. The title of the report is “Companion Diagnostics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.”

As per the report, the increasing demand for personalized medicines is the key factor fuelling the growth of the market for companion diagnostics. In addition, the rising occurrence of cancer globally and the reducing costs of drug development are also augmenting the growth of the market.

Factors such as the rising focus on targeted therapies and the focus of pharmaceutical companies on the in-house advancement of companion diagnostics are also augmenting the growth of the market. Furthermore, the increasing new indication areas have emerged as a key opportunity in the market.

Browse Full Research Report: https://www.transparencymarketresearch.com/companion-diagnostics-market.html

On the other hand, the increasing duration of the approval process and the prolonged development time of companion diagnostics may impede the growth of the market in forthcoming years. The unfavorable reimbursement scenario globally may also have a negative impact on the growth of the market in the coming years, as stated in this report.

Companion diagnostics are various procedures or tests utilized by healthcare professionals in making enhanced treatment decisions for patients as per the patients’ response to particular ongoing treatments. Companion diagnostics aid a health care professional to determine the effects of a specific therapeutic product on patients and any potential risks or side effects associated with its usage. The healthcare professional then adjusts his treatment to achieve enhanced effectiveness and safety.

On the basis of indication, the report segments the companion diagnostics market into lung cancer, breast cancer, gastric cancer, colorectal cancer, melanoma, and others including HIV and thalassemia. Amongst these, in 2012, the segment of breast cancer led the market on the basis of revenue. However, in forthcoming years, the segment of lung cancer will dominate the market, expanding at a CAGR of more than 20% between 2013 and 2019. This is owing to the discovery of myriad relevant companion diagnostics as well as the discovery of lung-cancer-specific biomarkers.

In terms of geography, the report segments the market into Europe, North America, Asia Pacific, and Rest of the World (RoW). Amongst these, in 2012, the market for companion diagnostics was dominated by the region of North America and this region held a share of over 35% in the market on the basis of revenue. This is because of the increasing consumer base due to the increasing count of cancer patients, rising affordability, increasing awareness about personalized healthcare, and the presence of sophisticated medical equipment in this region. On the other hand, the increased adoption of innovative medical procedures, the rising disposable incomes of consumers, and the rising healthcare infrastructure will also fuel the Latin America and Asia Pacific companion diagnostics markets.

According to the study, the chief players operating in the market are Roche Holdings AG, Qiagen N.V., Agilent Technologies, Inc., Agendia N.V., Abbott Laboratories, Genomic Health, Inc., GE Healthcare Ltd., and Life Technologies Corporation, among others.